CirrusDx, Inc. developed LacP™, its Lactobacillus Panel that characterizes and quantifies key Lactobacillus species to provide clinicians with a more complete understanding of the vaginal microbiome.
Public source
Publisher name
Public post
A healthy vaginal microbiome isn't defined only by what's present; it's also defined by what's protecting it. Protective Lactobacillus species play a critical role in ma…
Company
CirrusDx, Inc.
Culturing answers for faster, smarter patient care.
- Industry
- Hospitals and Health Care
- Location
- Rockville, US
- Company size
- 51–200 employees
About CirrusDx, Inc.
CirrusDx – Culturing answers for faster, smarter patient care At CirrusDx, we empower clinicians and support patients with personalized service paired with tests that look at infections differently, thus enabling faster, more informed care. Our CLIA-certified lab specializes in UTI, STI, vaginitis, wound, and respiratory infection testing, with a focus on improving outcomes in women’s health. What sets CirrusDx apart? We are committed to fully working up patient samples for deeper, actionable diagnostic insight. Unlike many labs that may not provide an actionable result, we focus on what grows—and how. This approach uncovers infection complexity, antibiotic resistance patterns, and effective treatment options, helping clinicians deliver precise, patient-centered care. Next-Level Integrated Testing Our integrated diagnostics combine molecular techniques with modernized culture, giving clinicians and their patients a comprehensive view of infections—including which pathogens are present, how they grow and interact, and how they respond to antibiotics. At the core of our integrated approach is polyMIC, our leading edge culture methodology that identifies antibiotic susceptibilities and provides clinically actionable guidance for personalized, patient-focused treatment. With rapid turnaround, responsive service (a real person answers the phone!), and a dedicated clinical team, CirrusDx helps clinicians move from questions to answers—supporting better outcomes for every patient. Learn more at www.cirrusdx.com.
See moreDiscover more
Similar signals
Similar public activity from other companies.
Products & Services
Hardy Diagnostics
Hardy Diagnostics launched Strep B Carrot Broth™ One-Step, a one-step GBS screening solution with no confirmatory testing needed for positives.
Products & Services
Lusis Biosciences
Lusis Biosciences engineered multi-plexing, flexible panel configurations, and built-in internal controls to help labs efficiently identify key STI targets.
Products & Services
Molecular Testing Labs
Molecular Testing Labs launched a comprehensive hormone testing portfolio including 11 individually orderable biomarkers and 5 clinically curated panels for women, fertility, perimenopause, postmenopause, and men's health.
Products & Services
Randox
Randox released the Evidence MultiSTAT Critical Care Biochips, leveraging Randox Biochip Array Technology to deliver biomarker profiling in 30 minutes from a single sample.
Products & Services
ARUP Laboratories